In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition

Transplantation

Volumn 72, Issue 12, 2001, Pages 1890-1897

  Hou, Guihua ^a,b   Valujskikh, Anna ^a,b   Bayer, Jörg ^a,b   Stavitsky, Abram B ^c   Metz, Christine ^d   Heeger, Peter S ^a,b,c,e  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b SHANDONG UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PICOWER INST FOR MEDICAL RESEARCH   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; FEMALE; GRAFT REJECTION; IN VIVO STUDY; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION INHIBITION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE;

EID: 0035666347     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200112270-00005     Document Type: Article

References (47)

1. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice
2. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: Identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants
3. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens
4. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection
5. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations
6. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice
7. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice
8. Role of indirect allorecognition in experimental late acute rejection
9. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
10. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
11. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
12. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system
13. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice
14. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
15. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat
16. The emerging role of MIF in septic shock and infection
17. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria
18. Protection from septic shock by neutralization of macrophage migration inhibitory factor
19. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
20. Alloreactive delayed-type hypersensitivity in graft recipients: Complexity of responses and divergence from acute rejection
21. Patterns of allosensitization in allograft recipients: Long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity
22. Trans vivo analysis of human delayed-type hypersensitivity reactivity
23. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat
24. Macrophage migration inhibitory factor expression in human renal allograft rejection
25. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen
26. CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma
27. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
28. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells
29. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen
30. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice
31. "Intrinsic" immunological tolerance in allophenic mice
32. Evidence that the effector mechanism of skin allograft rejection is antigen-specific
33. Acute rejection of vascularized heart allografts in the absence of IFNgamma
34. IL-2 and IL-4 double knockout mice reject islet allografts: A role for novel T cell growth factors in allograft rejection
35. MIF
36. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase
37. The role of tumor necrosis factor in allograft rejection: III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection
38. Expression of TGF-beta1 and matrix proteins is elevated in rats with chronic rejection
39. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection
40. Thromboxane and prostacyclin synthesis in experimental pancreas transplantation. Changes in parenchymal and vascular prostanoids
41. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts
42. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization
43. Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin
44. The severity of irritant contact dermatitis in various strains of mice correlates with endothelial expression of migration inhibitory factor (MIF)
45. Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts
46. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids
47. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes